Turbu+ Italia

Turbu + is a program intended to help people with asthma and / or COPD.

You will only be able to participate in the Turbo + program if you sign up with your doctor. Turbo + is a program that aims to assist people with asthma and / or COPD in monitoring the correct use of their prescribed medication. Users will interact with the program through a mobile app. This mobile app receives, stores and displays the inhalations and use of the drug with remote sensors present in the device (Turbo + ™) for monitoring enabled via compatible Bluetooth connected to the user's inhaler. The app also provides users with pre-configured reminders for correct drug intake. The Turbo + ™ program is not intended for:

• Diagnose, determine, modify or adapt the doctor's treatment decisions

• Monitor, in real time, the use of the drug by the user

• Determine or modify the user's treatment or pharmaceutical plan or recommend such changes

• Alter or analyze information on the use of the inhaler, without formatting the data for viewing.

Turbo + ™ is a patient support program which has been designed, developed and fully sponsored by AstraZeneca UK Ltd. The Turbo + ™ app has been developed by AstraZeneca UK Ltd, whose registered office is at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA. United Kingdom The Turbo + ™ device was designed and developed by Adherium New Zealand Ltd.

Last updated 06/22 Veeva ID: IT-7294